Cannvas MedTech (CSE:MTEC), a leading business technology company in the cannabis space, is pleased to announce that the company has exceeded quarterly growth targets and has tripled its number of employees in 2018. Growth in key departments with highly skilled individuals allows Cannvas to remain focused on pushing forward with its first product offering for the global cannabis markets:, a global cannabis education platform.

The Company’s most recent hire is David Davidzon, an accomplished brand strategist and creative writer with deep roots in the food and beverage industry, with over 10 years’ experience in corporate branding communications and public relations, digital marketing and social media, joins Cannvas as Marketing Manager. The Company also announces the appointment of Stacey Paterson (Registered Nurse) to its Health and Innovation Advisory Board. Paterson joins Daniel J. Bal, MD and Shirish Patel, MD also recently appointed to the board which oversees content related to the platform.

“I am very pleased to welcome two outstanding individuals David Davidzon and Ms. Stacey Paterson (Registered Nurse) to our Company,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Mr. Davidzon is a highly skilled brand strategist that brings with him a depth of experience to our marketing team. Ms. Paterson brings to our panel unique insights from emergency rooms of the Canadian hospital system, from years of experience from dealing with real patient needs. Our recent appointments will work to keep our articles, education modules, and interactive support technologies relevant for the Canadian Cannabis Community. It takes great people to make a great product and we have accelerated our growth to ensure the timely launch of I look forward to working with David and Stacey as we prepare to launch the platform and transform the medical cannabis landscape.”

David Davidzon has worked with Luminato, BMO, The Royal Conservatory of Music and Canadian subsidiary of Aroma Espresso Bar, developing and successfully executing promotional campaigns, procuring strategic partnerships and managing live events with high-profile artists. As a skilled storyteller and avid consumer of popular culture, Daniel does his best to sneak his personal interests into professional endeavours, resulting in memorable national campaigns and taglines.

As a member of the Health and Innovation Advisory Board Ms. Paterson will participate in the review of content to be published on platform, oversee research studies and provide insight from an ICU nurse and clinical perspective. Ms.Paterson currently works as an Intensive Care Nurse at several Greater Toronto Area hospitals and has specialized working on the neurology, medical/surgical/transplant, cardiac and critical care units. She holds a Bachelor of Nursing from the University of New Brunswick plus Certificates in Critical Care and Nephrology.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted

For further information: Media Inquiries:; Investor Relations:, 1-800-489-0116

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation. 


Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less